Ta Ann O'Rak (the doctor formerly known as Paul)
I wonder if the solution to the cost-benefit equation might be to have
hi-dose B12 available at just a few centres here and there, like snake
anti-venom.
House fire smoke exposure is not that uncommon. The victims that reach
A&E still ticking must have already survived 30 minutes or so. Is
another 30 minutes (while being resucitated / oxygenated etc.)
acceptable whilst the B12 is being sent to us rapidly from a local
store? A job for the ambulance service rapid response vehicle, or
police?. Matt alluded to the urgency of dosing in his response.
I suspect the efficacy question may never be more rigorously tested, but
the time-dependency question is of pragmatic importance to costing, if
not all centres can afford to store.
Does anyone remember seeing loads of emails about "pods" to be rapidly
distributed from regional stores in event of terrorist attack? Did
anyone of them include concentrated B12?
Goat
In message <000401c3555a$17c3a060$89864ed5@pransom>, Paul Ransom
<[log in to unmask]> writes
>CURRENT STATUS OF THE CYANOKIT
>At present Cyanokit is being championed by Orphan Europe, a company who
>represents pharmaceutical products with a clinical niche but for which
>there is little financial incentive for drug companies to market due to
>the small numbers involved.
Dr G Ray
A&E
Sussex
Reply to [log in to unmask]
|